Analysts' Top 5 Price Targets of February 3, 2026
Reading Time: 3 minutes
Evotec [DE0005664809] Berenberg starts coverage with Buy and a price target of €10 (60% upside potential) Analyst Christian Ehmann describes the company as a globally recognized contract research organization that provides pharmaceutical companies with comprehensive solutions along the entire value chain of drug research and development. Evotec benefits from two central trends - the increasing outsourcing needs of large pharmaceutical companies and their ongoing pressure to reduce research costs and make development processes more efficient....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
